Protagenic Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Protagenic Therapeutics has a total shareholder equity of $3.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.3M and $655.3K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$4.06m |
Equity | US$3.67m |
Total liabilities | US$655.25k |
Total assets | US$4.32m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PTIX's short term assets ($4.2M) exceed its short term liabilities ($655.3K).
Long Term Liabilities: PTIX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PTIX is debt free.
Reducing Debt: PTIX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PTIX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PTIX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.8% each year